The Polaris Innovation Fund aims to accelerate the commercial and therapeutic potential of early-stage
academic research. By partnering with passionate entrepreneurs with transformational science, the
Polaris Innovation Fund fosters company creation and growth through an active investment model. Our team
brings decades of experience in healthcare investing and entrepreneurship to our guidance of early stage companies.
This team of proven leaders in scientific research, biopharma, and venture capital investment
joined together for the sole purpose of bringing biomedical innovation to the market.
Cambridge, MA
Glympse Bio is transforming disease monitoring with a novel class of highly tunable and bioengineered activity sensors that query the body for disease status and report out clinically relevant insights rapidly and noninvasively.
Co-Founder
San Francisco, CA
Candesant is dedicated to developing novel solutions for excessive sweating and hyperhidrosis
CEO
New York, NY
Kallyope is developing an industry-leading platform to harness the gut-brain axis.
CEO
Boston , MA
CEO
Menlo Park, CA
Gauss’ iPad-based Triton platform uses digital imaging and Artificial Intelligence to enable real time monitoring of surgical blood loss. The company’s platform is being used to address preventable maternal death and health complications in childbirth and surgery.
Founder and CEO
Cambridge, MA
Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest disease.
CEO
Seattle, WA
KenSci is a healthcare data science company that uses machine learning to provide operational and clinical insights for hospital and health systems.
CEO
New York, NY
Nomad Health is a workforce marketplace that facilitates the hiring of physicians and nurses on behalf of healthcare provider organizations.
CEO
Cambridge, MA
NYSE: SQZ
SQZ Biotech is the pioneering company whose CellSqueeze cell therapy platform enables a variety of materials to enter a cell with unprecedented efficacy.
CEO
Cambridge, MA
Suono Bio, Inc. enables ultrasonic targeted delivery of therapeutics and macromolecules across tissues without the need for reformulation or encapsulation. Preclinical studies have demonstrated the capacity to deliver small molecules, proteins, vaccines, and nucleic acids locally to specific tissues such as the gastrointestinal tract, as well as systemically in a formulation-independent manner.
CEO
New York, NY
Quentis is at the forefront of the next generation of immuno-oncology drug development to help all cancer patients benefit from immunotherapy.
CEO
San Mateo, CA
NASDAQ: KRON
Kronos Bio is dedicated to the discovery and development of novel small molecule modulators of historically undruggable oncology targets.
CEO
Belgium
Montis Biosciences is targeting perivascular macrophages to restore tumor micro environment vasculature- increase immune infiltration and alleviate the immune suppressive TME.
Executive Chairman
Mountain View, CA
Amunix is a platform company developing technology for tumor-specific activation of T-cell engagers.
CEO
New York, NY
Thirty Madison is an end-to-end digital health platform that connects patients directly to provider specialists.
New York, NY
ByHeart is a fully integrated infant nutrition company dedicated to translating leading nutrition science and breastmilk research into products that set the best foundation for babies’ health.
CEO & Co-Founder
President & Co-Founder
Cambridge, MA
QurAlis is developing precision therapies for the treatment of ALS.
Founder & CEO
The Netherlands
Vico Therapeutics is developing therapies for rare neurological diseases, leveraging RNA modifying technologies.
Founder
New York, NY
Volastra is a preclinical oncology company targeting chromosomal instability in metastatic cancers.
San Francisco, CA
Sesh Therapy offers online support group sessions facilitated by a trained therapist.
CEO & Co-Founder
Boston, MA
Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer.
President & Co-Founder
San Diego, CA
IconOvir engages in research and development in cancer viral gene therapy.
President & CEO
Palo Alto, CA
The One Health Company, maker of FidoCure®, is bringing the latest advances in human oncology – individualized, precision medicine – to dogs with cancer.
Founder & CEO
One Marina Park Drive, 10th Floor
Boston, MA 02210
General inquiries: partnership@polarispartners.com